222 related articles for article (PubMed ID: 14620520)
1. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.
McNamara DP; Whitney KM; Goss SL
Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520
[TBL] [Abstract][Full Text] [Related]
2. Is bicarbonate buffer suitable as a dissolution medium?
Boni JE; Brickl RS; Dressman J
J Pharm Pharmacol; 2007 Oct; 59(10):1375-82. PubMed ID: 17910812
[TBL] [Abstract][Full Text] [Related]
3. Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO
Al-Gousous J; Sun KX; McNamara DP; Hens B; Salehi N; Langguth P; Bermejo M; Amidon GE; Amidon GL
Mol Pharm; 2018 Nov; 15(11):5291-5301. PubMed ID: 30362350
[TBL] [Abstract][Full Text] [Related]
4. Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.
Scott N; Patel K; Sithole T; Xenofontos K; Mohylyuk V; Liu F
Int J Pharm; 2020 Jul; 585():119562. PubMed ID: 32565282
[TBL] [Abstract][Full Text] [Related]
5. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.
Sheng JJ; McNamara DP; Amidon GL
Mol Pharm; 2009; 6(1):29-39. PubMed ID: 19183104
[TBL] [Abstract][Full Text] [Related]
6. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
[TBL] [Abstract][Full Text] [Related]
7. In vivo predictive dissolution: transport analysis of the CO2 , bicarbonate in vivo buffer system.
Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
J Pharm Sci; 2014 Nov; 103(11):3473-3490. PubMed ID: 25212721
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
Salehi N; Al-Gousous J; Mudie DM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2020 Oct; 17(10):3870-3884. PubMed ID: 32886520
[TBL] [Abstract][Full Text] [Related]
9. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
Sakamoto A; Sugano K
Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
[TBL] [Abstract][Full Text] [Related]
10. Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.
Okamoto N; Higashino M; Yamamoto H; Sugano K
Pharm Res; 2024 May; 41(5):959-966. PubMed ID: 38653942
[TBL] [Abstract][Full Text] [Related]
11. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
[TBL] [Abstract][Full Text] [Related]
12. The effect of buffer species on biorelevant dissolution and precipitation assays - Comparison of phosphate and bicarbonate buffer.
Krollik K; Lehmann A; Wagner C; Kaidas J; Kubas H; Weitschies W
Eur J Pharm Biopharm; 2022 Feb; 171():90-101. PubMed ID: 34592364
[TBL] [Abstract][Full Text] [Related]
13. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
14. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Liu F; Shokrollahi H
Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
[TBL] [Abstract][Full Text] [Related]
15. Solubility vs Dissolution in Physiological Bicarbonate Buffer.
Claussen F; Al-Gousous J; Salehi N; Garcia MA; Amidon GL; Langguth P
Pharm Res; 2024 May; 41(5):937-945. PubMed ID: 38698196
[TBL] [Abstract][Full Text] [Related]
16. Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.
Fadda HM; Merchant HA; Arafat BT; Basit AW
Int J Pharm; 2009 Dec; 382(1-2):56-60. PubMed ID: 19666093
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases.
Krieg BJ; Taghavi SM; Amidon GL; Amidon GE
J Pharm Sci; 2015 Sep; 104(9):2894-904. PubMed ID: 25980464
[TBL] [Abstract][Full Text] [Related]
18. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
19. Mass Transport Analysis of Bicarbonate Buffer: Effect of the CO
Al-Gousous J; Salehi N; Amidon GE; Ziff RM; Langguth P; Amidon GL
Mol Pharm; 2019 Jun; 16(6):2626-2635. PubMed ID: 31013101
[TBL] [Abstract][Full Text] [Related]
20. Drug Crystal Precipitation in Biorelevant Bicarbonate Buffer: A Well-Controlled Comparative Study with Phosphate Buffer.
Yamamoto H; Sugano K
Mol Pharm; 2024 Jun; 21(6):2854-2864. PubMed ID: 38718215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
